Health

Healthcare adoption still trails other industries in AI use, and public trust remains limited, which reinforces the need for strategic leadership, clear guardrails, and responsible implementation.  There’s more attention, more …

Apnimed, a sleep disorders drug developer whose lead therapeutic candidate is under FDA review, raised $192 million in a stock market debut that will support commercialization plans for its pill …

Virginia-based health system Sentara Health has notified Anthem Blue Cross Blue Shield that it will let its commercial, Medicare and Medicaid contracts expire at the end of the year if …

Editor’s Note: This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive. Health tech companies made several …

More than three-quarters of health system and hospital executives plan to expand participation in value-based care (VBC) models over the next two years, up from 57% in 2023. But despite …

Not long ago I read a vendor pitch for an AI documentation tool. The selling point, stated almost as a victory: the system listened to the visit, settled on a …

In chronic kidney disease (CKD), medication adherence depends on coordinated, interdisciplinary care that helps patients manage complex regimens, avoid preventable errors, and improve long-term outcomes. Medication adherence is central to …

​Every day, healthcare teams are left to complete work across systems that were never designed to work together. They chase the next step, correct errors, close gaps, and keep care …

Daffodil Health, an AI health plan administration platform, unveiled a new solution on Thursday that aims to help payers manage No Surprises Act disputes. The No Surprises Act shields patients …

Pharmaceutical companies often point to slow clinical trial enrollment as a chokepoint for drug development, but it’s no picnic for patients either. Physicians may be able to suggest a trial …